Avermectin Powder CAS 71751-41-6

The core quality difficulty of avermectin API lies in the stability of microbial fermentation process. Many small factories adopt unstable strain activation and fermentation culture technology, resulting in fluctuating active component content, inconsistent color and uneven efficacy between batches. Our factory applies fixed high-quality strain banks, standardized temperature and oxygen control fermentation systems, and staged metabolic regulation technology. The whole fermentation process is digitally monitored, and post-purification and crystallization processes are strictly controlled to ensure consistent active component ratio, stable purity indicators and unified powder appearance in each batch, minimizing finished product efficacy deviation caused by raw material batch differences.

Fermentation-derived APIs are prone to microbial impurities, protein residues and solvent residues, which will cause solution turbidity, precipitate generation and unqualified residue detection of downstream finished preparations. We adopt multi-stage membrane filtration, high-precision recrystallization and vacuum drying processes to effectively remove macromolecular impurities and residual solvents. Each batch is tested by HPLC and residual solvent detection equipment to strictly control impurity content, ensuring that the raw materials meet the production requirements of qualified standard liquid solutions, external spray agents and pour-on preparations, helping customers pass local market sampling inspections smoothly.

Different downstream formulation scenarios have distinct requirements for avermectin powder physical properties. External spray and liquid formulations require fine particle size and excellent dispersion performance; feed premix production demands stable powder fluidity to avoid agglomeration and component stratification; high-purity compound formulations require low impurity and stable active ingredient content. Based on years of fermentation production and formula matching experience, we can adjust powder fineness, particle size distribution and bulk density within industry standard ranges according to customers' production processes, simplifying customers' secondary processing and improving finished product qualification rates.

Fermentation-grade veterinary API exports are subject to stricter overseas regulatory supervision compared with chemically synthesized raw materials, especially in production traceability and impurity control standards. As a direct fermentation manufacturer, we provide authentic, audit-able and complete document sets including batch COA, SDS, production qualification files, fermentation process records and impurity spectrum reports. All documents comply with international export standards, supporting customers' daily customs clearance and veterinary product registration in Southeast Asia, Africa, Latin America and other mainstream overseas markets, helping customers avoid market entry barriers caused by incomplete documentation.

Animal parasite prevention and control presents obvious seasonal demand fluctuations, which easily cause market supply shortages and price instability in peak seasons. We own dedicated avermectin fermentation workshops and independent purification production lines with steady annual output capacity. We maintain year-round conventional safety stock to cope with seasonal demand growth and raw material market fluctuations. We support laboratory sample testing, small-batch trial production and large-tonnage long-term framework cooperation orders, ensuring stable and on-time shipment for all customer orders throughout the year.